The anti-inflammatory effect of glucocorticoids in septic systemic inflammation is well documented, and in a previous experimental study of ours [18], we concluded that steroid treatment prior to endotoxemia had beneficial circulatory effects, which were not mediated by TNF-alpha, IL-6, or NO. The gene discussed is IL6; the disease is serum lipopolysaccharide activity.